AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression
Open Access
- 1 January 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (4), 2737-2746
- https://doi.org/10.1074/jbc.m309999200
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Rapamycin-induced Translational Derepression of GCN4 mRNA Involves a Novel Mechanism for Activation of the eIF2α Kinase GCN2Journal of Biological Chemistry, 2003
- Translational control by TOR and TAP42 through dephosphorylation of eIF2α kinase GCN2Genes & Development, 2003
- Evidence That Cyclin D1 Mediates Both Growth and Proliferation Downstream of TOR in HepatocytesPublished by Elsevier ,2003
- TOR signalling in bugs, brain and brawnNature Reviews Molecular Cell Biology, 2003
- ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTRGenes & Development, 2002
- Global and Specific Translational Control by Rapamycin in T Cells Uncovered by Microarrays and ProteomicsJournal of Biological Chemistry, 2002
- Role of Translation Initiation Factor 2B in Control of Cell Survival by the Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3β Signaling PathwayMolecular and Cellular Biology, 2002
- Mammalian TOR: A Homeostatic ATP SensorScience, 2001
- Derivation of a structural model for the c-myc IRES11Edited by J. KarnJournal of Molecular Biology, 2001
- C-Myc 5′ untranslated region contains an internal ribosome entry segmentOncogene, 1998